重症监护病房收治的颅外抗凝相关出血:法国多中心回顾性研究
该研究为法国五家ICU的回顾性观察研究,纳入2007年1月至2018年12月因治疗性抗凝期间发生颅外出血而入ICU的486例成年患者。患者以男性为主(61%),平均年龄73±13岁,多伴有高血压(68%)、心脏病(49%)和糖尿病(33%)。抗凝药以维生素K拮抗剂(VKA,54%)为主,肝素25%,直接口服抗凝药(DOAC)7%;ICU收治的抗凝相关出血发病率从2007年3.2/1000升至2018年5.8/1000,DOAC类增幅尤为明显。入院时器官衰竭严重(SOFA评分7±4),31.5%需血管升压药、34%需有创机械通气,针对抗凝相关出血的特异性治疗指南依从性普遍较低,ICU死亡率27%。多因素分析显示慢性高血压、需血管升压药、意识障碍、高乳酸血症和aPTT延长>1.2倍与死亡独立相关。
要点
- 法国五家ICU 2007至2018年因抗凝相关颅外出血入ICU的发病率从3.2/1000升至5.8/1000,DOAC类增幅尤为明显。
- 486例患者中VKA占54%、肝素25%、DOAC 7%;入院SOFA评分7±4,31.5%需血管升压药,34%需有创机械通气。
- 针对抗凝相关出血的特异性治疗指南依从性普遍较低,ICU死亡率27%。
- 多因素分析中与死亡独立相关的5个因素:慢性高血压、需血管升压药、意识障碍、高乳酸血症、aPTT延长>1.2倍。
- 作者认为治疗管理欠佳,可通过教育项目改善。
适用人群与场景
- 2007年1月至2018年12月入住法国五家ICU、年龄超过18岁、因治疗性抗凝期间发生颅外出血的患者。
研究设计与关键结果
- 研究类型:法国五家ICU的回顾性观察研究;纳入486例因治疗性抗凝期间颅外出血入ICU的成年患者,男性61%,平均年龄73±13岁。
- 合并症:高血压68%、心脏病49%、糖尿病33%;抗凝药:VKA 54%、肝素25%、DOAC 7%。
- ICU收治的抗凝相关出血发病率从2007年3.2/1000升至2018年5.8/1000,DOAC类增幅尤为明显。
- 入院时SOFA评分7±4,31.5%需血管升压药,34%需有创机械通气;针对抗凝相关出血的特异性治疗指南依从性普遍较低;ICU死亡率27%。
- 多因素分析:慢性高血压、需血管升压药、意识障碍、高乳酸血症、aPTT延长>1.2倍与死亡独立相关。
证据类型、等级与局限
- 证据类型:回顾性观察研究;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为抗凝相关颅外出血需ICU收治是导致器官衰竭和显著死亡的严重并发症,其发病率在上升。
- 作者认为治疗管理欠佳,可通过教育项目改善。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Anticoagulants are widely used but can lead to iatrogenic events such as bleeding. Limited data exists regarding the characteristics and management of patients admitted to intensive care units (ICU) for severe anticoagulant-related extracranial bleeding.
METHODS: A retrospective observational study was conducted in five French ICUs. From January 2007 to December 2018, all patients aged over 18 years admitted to ICU for extracranial bleeding while receiving therapeutic anticoagulation were included.
RESULTS: 486 patients were included, mainly male (61%) with an average age of 73 ± 13 years. Most patients had comorbidities, including hypertension (68%), heart disease (49%) and diabetes (33%). Patients were treated by vitamin K antagonists (VKA, 54%), heparins (25%) and direct oral anticoagulants (DOAC, 7%). The incidence of patients admitted to ICU for anticoagulant-related bleeding increased from 3.2/1000 admissions in 2007 to 5.8/1000 in 2018. This increase was particularly high for DOAC class. Upon admission, patients exhibited severe organ failure, as evidenced by a high SOFA score (7 ± 4) and requirement for organ support therapies such as vasopressors (31.5%) and invasive mechanical ventilation (34%). Adherence to guidelines for the specific treatment of anticoagulant-related bleeding was generally low. ICU mortality was 27%. In multivariate analysis, five factors were independently associated with mortality: chronic hypertension, need for vasopressors, impaired consciousness, hyperlactatemia and prolonged aPTT > 1.2.
CONCLUSION: Anticoagulant-related extracranial bleeding requiring ICU admission is a serious complication responsible for organ failure and significant mortality. Its incidence is rising. The therapeutic management is suboptimal and could be improved by educational programs.
参考来源
- Botrel T, Cunat S, Helms J, et al. Extracranial anticoagulant related bleedings admitted to intensive care units: a French multicenter retrospective study. Crit Care. 2023. PMID: 37559102. doi:10.1186/s13054-023-04605-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。